Lori Wink
Women's Health · Houston, TXNPI 1295279750
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 35.8% of the total. Reporting peaked in 2023 at $6,348 and has fallen 90.1% since, to $627 in 2025. Among women's health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 134 payments — averaging $65.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$3K
- Pfizer$3K
- Myovant Sciences Inc.$497
- Astellas Pharma Global Development$333
- Mayne Pharma Commercial LLC$185
- Bayer$179
- plus $1K from 23 others
What the payments were for
- Speaking & faculty fees$4,29649%
- Travel & lodging$1,08512%
- Food & beverage$3,42139%
- Gifts$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $3,160 |
| Pfizer | 11 | $3,129 |
| Myovant Sciences Inc. | 16 | $497 |
| Astellas Pharma Global Development | 7 | $333 |
| Mayne Pharma Commercial LLC | 12 | $185 |
| Bayer | 4 | $179 |
| AbbVie | 7 | $162 |
| Astellas Pharma US Inc | 8 | $152 |
| Biogen | 6 | $150 |
| Exeltis, USA Inc. | 7 | $123 |
| Shield Therapeutics Inc | 8 | $122 |
| Therapeuticsmd, Inc. | 6 | $97 |
| Organon | 4 | $79 |
| Evofem Biosciences, Inc. | 4 | $67 |
| Millicent US Inc | 3 | $60 |
| Ascend Therapeutics US, LLC | 3 | $41 |
| Avion Pharmaceuticals | 2 | $34 |
| Gynesonics, Inc. | 1 | $32 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Mission Pharmacal Company | 1 | $23 |
| Merck | 1 | $23 |
| Aspira Women's Health Inc | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Coopersurgical, Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $20 |
| Abbott | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Agile Therapeutics, Inc. | 1 | $16 |
| Lupin Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,820 in reported general payments places this provider in the 95th percentile of 609 women's health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $1,595 |
| Metronidazole | 12 | $256 |
Paid to pharmacies, not to this prescriber.
Other women's health in Houston
- Joann St PierreHouston$15K
- Andrea DunnHouston$6K
- Kim GustafsonHouston$4K
- Erica SmithHouston$4K
- Christie LouisHouston$3K
- Mary UmbleHouston$3K
- Kim OkewunmiHouston$3K
- Kathryn AckermanHouston$2K
- Evelyn TingGrapevine$89K
- Christina TrumanWaco$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.